Variable | HREC n = 635 | Routine care n = 4323 | p value |
---|---|---|---|
Male gender | 256 (40%) | 1749 (41%) | 0.945 |
Median (IQR) age | 35.8 (30.5-42.4) | 36.7 (30.6-43.1) | 0.097 |
Median (IQR) CD4 at initiation of cART | 46 (20-72) | 46 (20-74) | 0.908 |
WHO Clinical Stage III/IV at initiation of cART | 418 (66%) | 2966 (69%) | 0.031 |
Missing | 0 (0%) | 89 (2.1%) | Â |
On TB treatment at cART initiation | 204 (32%) | 1514 (35%) | 0.152 |
Clinic type | Â | Â | Â |
Referral hospital | 217 (34%) | 903 (21%) | < 0.001 |
District and sub-district hospitals | 221 (35%) | 2107 (49%) | Â |
Rural health centres | 197 (31%) | 1313 (30%) | Â |
Use of cotrimoxazole or dapsone within 28 days of cART initiation | 632 (100%) | 4097 (95%) | < 0.001 |
Travel > 1 h to clinic | 452 (71%) | 3318 (77%) | 0.002 |